Hospital Acquired Infection Control Market to Grow at 4.21% CAGR through 2029

Growing healthcare expenditure and technological advancements in infection control is expected to drive the Global Hospital Acquired Infection Control Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “Hospital Acquired Infection Control Market – Global Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2019-2029F”, the Global Hospital Acquired Infection Control Market stood at USD 29.78 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.21% through 2029. The Global Hospital Acquired Infection (HAI) Control Market presents a dynamic landscape shaped by a myriad of factors, including technological advancements, regulatory standards, healthcare infrastructure, and infectious disease trends. In recent years, the market has witnessed significant growth driven by an increasing awareness of the burden of HAIs on patient safety and healthcare costs, coupled with a growing emphasis on infection prevention and control measures worldwide.

One of the key drivers of the Global HAI Control Market is the rising prevalence of healthcare-associated infections, which pose a significant threat to patient safety and contribute to morbidity, mortality, and increased healthcare expenditures. HAIs encompass a broad spectrum of infections acquired during the course of medical treatment in healthcare facilities, including hospitals, clinics, and long-term care settings. Common types of HAIs include surgical site infections, bloodstream infections, urinary tract infections, and pneumonia.

The economic burden associated with HAIs is substantial, with healthcare costs estimated to be in the billions of dollars annually. In addition to direct medical costs related to prolonged hospital stays, additional treatments, and medication expenses, HAIs also result in indirect costs such as lost productivity, disability, and premature death. As a result, healthcare providers and policymakers are increasingly prioritizing infection prevention and control strategies to mitigate the impact of HAIs on patient outcomes and healthcare expenditures.

Technological advancements play a pivotal role in driving innovation in the HAI Control Market. Manufacturers are continually developing and introducing new infection control products and technologies designed to enhance the efficacy of disinfection, sterilization, and surveillance practices. This includes the development of automated disinfection systems, advanced sterilizers utilizing novel technologies such as hydrogen peroxide vapor and ultraviolet (UV) light, and sophisticated surveillance software capable of real-time monitoring and analysis of infection data.

Regulatory standards and guidelines also shape the landscape of the Global HAI Control Market, with government agencies and international organizations issuing recommendations and requirements for infection prevention and control practices in healthcare settings. Compliance with these standards is essential for healthcare facilities to ensure patient safety and maintain accreditation and certification.

The emergence of antimicrobial resistance poses a significant challenge to infection control efforts globally. The overuse and misuse of antibiotics have led to the proliferation of multidrug-resistant organisms (MDROs), making infections more difficult to treat and increasing the risk of transmission within healthcare settings. Addressing antimicrobial resistance requires a multifaceted approach that includes antibiotic stewardship programs, enhanced infection control measures, and the development of new antimicrobial agents.

The COVID-19 pandemic has further underscored the importance of infection prevention and control in healthcare settings. Healthcare facilities worldwide have implemented rigorous infection control protocols to prevent the spread of the virus, including enhanced cleaning and disinfection practices, the use of personal protective equipment (PPE), and the implementation of screening and testing measures. The pandemic has also accelerated the adoption of telehealth and remote monitoring technologies, reducing the need for in-person visits and minimizing the risk of exposure to infectious agents.

The Global Hospital Acquired Infection Control Market is characterized by a growing awareness of the burden of HAIs, technological advancements, regulatory standards, and the ongoing challenge of antimicrobial resistance. As healthcare providers and policymakers continue to prioritize infection prevention and control, the market is poised for further growth and innovation in the years to come.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Hospital Acquired Infection Control Market”

The Global Hospital Acquired Infection Control Market is segmented into product, application, technology, disease, end user, regional distribution, and company.

Based on disease, the Hospital Acquired Pneumonia (HAP) emerges as a significant concern and a dominant focus area for infection control efforts. HAP refers to pneumonia that develops in patients during their hospital stay, typically 48 hours or more after admission, and is not present at the time of admission. This type of infection is often associated with invasive procedures, mechanical ventilation, and compromised immune systems, making it a prevalent and serious complication in healthcare settings worldwide.

Several factors contribute to the prominence of HAP in the HAI Control Market. Patients in intensive care units (ICUs) are particularly vulnerable to developing pneumonia due to factors such as prolonged mechanical ventilation, underlying medical conditions, and exposure to healthcare-associated pathogens. As a result, ICUs often implement stringent infection prevention measures to reduce the risk of HAP, including strict adherence to hand hygiene protocols, surveillance for ventilator-associated pneumonia (VAP), and the use of specialized respiratory equipment. HAP is associated with significant morbidity, mortality, and healthcare costs, making it a priority for healthcare providers and policymakers. Patients who develop HAP are more likely to experience complications, require extended hospital stays, and incur higher healthcare expenditures compared to those without HAP. Consequently, there is a growing emphasis on preventive strategies such as early detection, appropriate antibiotic therapy, and interventions to reduce the risk of aspiration and ventilator-associated events.

Based on region, after North America, Europe emerges as the second dominant region in the Global Hospital Acquired Infection (HAI) Control Market, wielding significant influence and contributing substantially to the advancement of infection control practices worldwide. Europe's prominence in the HAI Control Market is attributable to several key factors that underscore its leadership in infection prevention and control efforts. The region boasts a robust healthcare infrastructure characterized by well-established healthcare systems, state-of-the-art medical facilities, and a strong emphasis on patient safety and quality of care. European countries, including Germany, France, the United Kingdom, and the Nordic nations, prioritize infection control initiatives, investing in advanced technologies and evidence-based practices to mitigate the risk of HAIs.

Europe is home to a wealth of expertise in infectious diseases and infection control, with renowned academic institutions, research organizations, and healthcare professionals driving innovation and knowledge dissemination in the field. Collaborative efforts between academia, industry, and government agencies facilitate the development of cutting-edge infection control products, technologies, and guidelines tailored to the region's unique healthcare landscape. Regulatory standards and guidelines play a pivotal role in shaping infection control practices in Europe, with stringent regulations ensuring adherence to high standards of care and patient safety. The European Centre for Disease Prevention and Control (ECDC) and national health authorities provide guidance and support to healthcare facilities, fostering a culture of continuous improvement in infection prevention and control.

Major companies operating in Global Hospital Acquired Infection Control Market are:

• Becton, Dickinson and Company
• STERIS Plc
• Advanced Sterilization Products Services Inc.
• Getinge AB
• Kimberly-Clark Corporation
• Cantel Medical Corporation
• BioMérieux SA
• Belimed AG
• 3M Company
• Sterigenics International LLC

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The future of the Hospital Acquired Infection (HAI) Control Market is poised for dynamic growth and innovation as healthcare systems worldwide increasingly prioritize infection prevention and control. Technological advancements, coupled with heightened awareness of the impact of HAIs on patient safety and healthcare costs, will drive the development and adoption of novel solutions tailored to the evolving needs of healthcare facilities. Antimicrobial stewardship programs and surveillance systems will continue to play a critical role in combating antimicrobial resistance and detecting outbreaks of multidrug-resistant pathogens. The integration of artificial intelligence, big data analytics, and digital health technologies will revolutionize infection control practices, enabling real-time monitoring, predictive analytics, and targeted interventions to prevent HAIs.,” said Mr. Karan Chechi, Research Director, TechSci Research, a research-based management consulting firm.

“Hospital Acquired Infection Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Others), By Application (Disease Testing, Drug-Resistance Testing), By Technology (Phenotypic Methods, Genotypic Methods), By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others), By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Hospital Acquired Infection Control Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Hospital Acquired Infection Control Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com